Ruling resistance out, and reading the blank: genome-based antimicrobial susceptibility prediction in clinical Pseudomonas aeruginosa isolates
For two of the four antibiotics investigated here, clinically relevant findings can be generated today: the genome allows the identification of an isolate group with no indication of resistance, marks a smaller group as resistant, and assigns the remaining isolates to an intermediate range close to the clinical breakpo...